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1. Introduction 
Hypothyroidism is relatively a common disease worldwide. Overall prevalence in adults in 
the United States is 4.6%. (Golden et al., 2009) It can present as mild/subclinical form or overt 
hypothyroidism with a prevalence of 4.3% and 0.3% of adult populations, respectively. 
(Golden et al., 2009) Thyroid hormone deficiency has been linked to increased risk of 
cardiovascular morbidities and mortalities. (McQuade et al., 2011, Resta et al., 2004) 
Respiratory system like other body systems and organs is affected by hypothyroidism. The 
spectrum of diseases involvement can range from mild dyspnea to more severe and life-
threatening respiratory failure. Several pathophysiological mechanisms are responsible for the 
compromise in the respiratory system including reduction in central respiratory drive, 
respiratory muscle weakness and sleep-related breathing disorders (SBD). (Duranti et al., 1993, 
Saaresranta and Polo, 2002, Curnock et al., 1999) Hypothyroidism is characterized by 
mucopolysaccharides accumulation in the dermis, hypopharynx, tongue and other tissues. 
(Skatrud et al., 1981, Orr et al., 1981)  In its most severe form (myxedema), patients typically 
present with hypothermia, hypercapnia, hypotension and bradycardia. Both hypothyroidism 
and obstructive sleep apnea (OSA) share  common signs and symptoms. Increased fatigue and 
sleepiness, decreased cognitive function, decreased libido, obesity and depressed mood are 
common findings in both disorders. (Grunstein et al., 1993, Misiolek M and 2007, Chan et al., 
2010) Periorbital edema and pedal edema are other common findings in patients with either 
disorder. Nevertheless, snoring which is a hallmark of OSA is also reported in hypothyroid 
cases. (Misiolek M and 2007, Georgalas, 2011) The overlap between the two disorders may 
create a problem for the treating physician in differentiating both disorders and may result in a 
misdiagnosis or under-recognition of one of the disorders. Therefore, it is essential to consider 
both diseases in high risk patients and initiate the proper therapeutic plan accordingly. This 
chapter discusses how hypothyroidism interferes with respiratory physiology and then 
discusses the relationship between hypothyroidism and sleep disordered breathing. 
2. Obstructive Sleep Apnea (OSA)  
OSA is a disease characterized by repeated partial (hypopnea) or complete (apnea) collapse 
of the upper airway while asleep accompanied by surges in the sympathetic activity, cortical 
www.intechopen.com
 
Hypothyroidism – Influences and Treatments 
 
52
arousals and episodes of hypoxia. (Chan et al., 2010) Patients usually present with 
complaints of excessive daytime sleepiness, un-refreshing sleep, fatigue or insomnia.  
Patients might have nocturnal awakenings with breathe holding, gasping, or choking. (Park 
et al., 2011, Madani and Madani, 2009) Very frequently, the bed partner report breathing 
interruptions, loud snoring or both during patient’s sleep. The main risk factors for OSA are 
obesity, older age, family history, increasing neck circumference and male gender. 
(BaHammam et al., 2008, Tsara et al., 2010) Menopause is the main risk factor for women 
even after adjustment for age and body mass index (BMI). (Ancoli-Israel et al., 1989, Block et 
al., 1980) Other predisposing factors include craniofacial features, maxillomandibular 
malformation or adenotonsillar enlargements. (Johns et al., 1998, Moser and Rajagopal, 1987, 
Orr and Martin, 1981) The prevalence of OSA syndrome (AHI> 5/hour and excessive 
daytime sleepiness) is estimated to be 2% to 4% of adults. (Young et al., 2002, Punjabi, 2008) 
Epidemiologic data suggest that roughly 1 of every 5 adults has at least mild OSA and 1 of 
every 15 adults has at least moderate OSA. (Young et al., 2002) The National Sleep 
Foundation survey found that 26% of the population has a high probability of OSA. 
(Hiestand et al., 2006) It is always essential to identify and treat persons with OSA because 
of its strong association with several medical conditions, occupational and social 
consequences. Untreated OSA can result in increased risk of cardiovascular morbidities such 
as myocardial infarction, congestive heart failure, stroke, refractory hypertension, and 
cardiac arrhythmia. (Guilleminault et al., 1983, Logan and Bradley, 2010, Somers et al., 2008, 
Ehrmann et al., 2011) Furthermore, cognitive dysfunction, depression, impaired glucose 
tolerance, occupational and increased motor vehicle accidents are the other consequences. 
(Sateia, 2003, Kaplan, 1992, Horne and Reyner, 1999, Radun and Summala, 2004) Treatment 
with continuous positive airway pressure (CPAP) can help in restoring the airway and 
reversing the majority of the associated morbidities. (Jean-Louis et al., 2010, Ferini-Strambi 
et al., 2003)   
3. Hypothyroidism and the respiratory system 
Respiratory system components (respiratory center, upper airway and lower respiratory 
system) can be affected by deficiencies in body hormones as well as excess hormonal 
secretion. (Saaresranta and Polo, 2002, Saaresranta and Polo, 2003, Behan et al., 2003, 
Takasaki and Hayashi, 1985) Thyroid hormone is one of the major body hormones. Its 
deficiency has been associated with multiple cardiovascular complications, respiratory 
failure and coma. (McQuade et al., 2011, Takamura et al., 2010, Behnia et al., 2000, Hall and 
Scanlon, 1979) The involvement of the respiratory system has resulted in a spectrum of 
clinical disorders including SBD, pulmonary hypertension, hypoventilation and severe 
respiratory failure. The following section explains the mechanisms through which 
hypothyroidism affect the respiratory system. 
Ventilatory drive 
Hypothyroidism is associated with diminished ventilatory drive for both hypoxia and 
hypercapnia. In animal models of induced hypothyroidism, a decrease in peripheral 
chemoreceptor response to hypoxia and hypercapnia has been observed. (Simsek et al., 
2004) In humans, approximately, one third of the hypothyroid patients have a blunted 
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ventilatory response to hypoxia/hypercapnia. (Zwillich et al., 1975, Duranti et al., 1993, 
Massumi RA, 1964) Predictors of blunted ventilatory response in hypothyroidism have 
been identified as female gender and very high levels of thyrotropin (>90 mIU/l). 
(Ladenson et al., 1988)  It is the severe form of hypothyroidism that is associated with 
diminished ventilatory control. Cases of myxedema and severe hypothyroidism (thyroid 
ablation) were found to have a diminished hypoxic ventilatory drive that was reversible 
with hormonal replacement therapy. (Zwillich et al., 1975) However, diminished 
hypercapnic ventilator drive was only seen in myxedema cases and was not responsive to 
hormonal therapy. (Zwillich et al., 1975) In a case report of a patient with 
hypothyroidism, central sleep apnea with blunted ventilatory response to hypoxia but 
normal hypercapnic ventilatory response, treatment with thyroxine therapy have resolved 
the central apneas and restored the hypoxic drive. The normal hypercapnic ventilatory 
drive has doubled with thyroxine therapy. (Millman et al., 1983) Hypoxic ventilatory 
drive has a rapid response to thyroxine replacement than hypercapnic ventilator drive. It 
might be that the central chemoreceptors require longer duration of therapy or they 
sustain a long-term impairment. The use of intravenous thyroxine therapy was shown to 
improve both hypoxic and hypercapnic ventilatory drive within one week of therapy. 
(Duranti et al., 1993) Severe degrees of alveolar hypoventilation and coma have also been 
reported in cases of severe hypothyroidism (myxedema). (Behnia et al., 2000, Orr et al., 
1981, Wall, 2000, Jordan, 1995)  
Hypothyroidism is reported in 3% of difficult to wean mechanically ventilated patients. 
(Datta and Scalise, 2004) Despite this low rate, it is a potentially treatable cause and 
should be considered when evaluating patients who fail to wean. Successful weaning 
from ventilator following correction of hypothyroidism has been reported. (Pandya et al., 
1989) Difficulty in weaning can be multifactorial in hypothyroid patients due to the 
multiple effects exerted by the hormone deficiency on different levels of the respiratory 
system.  
Upper respiratory tract 
- Mechanical Obstruction: Enlargement of the thyroid gland (goiter) in the presence of 
hypothyroidism or euthyroid state can create a mass effect on the upper 
airway,(Deegan PC, 1997, De Felice et al., 2006, Eloy et al., 2007) particularly when 
resuming the supine position. Such mechanical obstruction becomes prominent and can 
be associated with severe apneas. (Teramoto et al., 1995) Progressive enlargement of the 
thyroid goiter can further lead to stridor and an emergency intervention might be 
required in such severe cases. (Deegan PC, 1997) Reports have showed improvement of 
OSA with thyroidectomy. (Agrama, 2011) 
- Soft Tissue Infiltration: As a part of the generalized skin and soft tissue infiltration in 
hypothyroidism, the upper airway and particularly the pharynx gets narrowed. In 
hypothyroidism, mucopolysaccharides and proteins infiltrate the skin causing skin 
thickening, infiltrate the tongue causing enlargement and infiltrate the neck soft tissue 
resulting in variable degrees of upper airway obstruction. (Devdhar et al., 2007, Batniji 
RK, 2006 , Watson and Pearce, 1949) Hypothyroidism also alters the  myosin heavy 
chain profile specifically in the main dilator muscle the genioglossus muscle, which 
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results in compromising the muscle function. (Petrof et al., 1992) Despite these changes 
in upper airway structure and function, hypothyroidism per se is not an independent 
risk factor for OSA if other known risk factors as male gender and obesity are not 
present. (Pelttari et al., 1994)  Upper airway obstruction in hypothyroid patients might 
not be very evident initially. During stressful situations, occult hypothyroidism can 
result in devastating outcomes such as in post-extubation upper airway obstruction 
following emergency intubation or post-operatively. Cases of severe emergency 
obstruction in undiagnosed hypothyroidism have been reported. (Sherry and 
Hutchinson, 1984, Stahl N, 1988)  
Lower respiratory tract 
As with upper respiratory tract, the different structures of the lower respiratory tract can be 
affected to a variable degree with alterations in thyroid hormone levels.  
- Airways: Very few studies have investigated airway diseases in hypothyroidism. In 
one study, patients with treated hypothyroidism were found to have more symptoms 
of breathlessness and wheeze. (Birring et al., 2003) And when evaluated by 
Methacholine challenge test, patients with treated hypothyroidism had more airways 
hyperreactivity than normal healthy individuals. Induced sputum showed higher 
levels of inflammatory cells, absolute neutrophil count, absolute lymphocyte count 
and increased levels of sputum interleukin-8 suggesting increased airway 
inflammation compared to control. (Birring et al., 2005) 
- The lung parenchyma: The interstitium can also be affected in hypothyroidism; two 
cases of lung fibrosis have been reported in patients with severe hypothyroidism. 
Initiating therapy for hypothyroidism was associated with significant clinical and 
radiological improvement in lung fibrosis. (George et al., 2009)  
- Respiratory Muscles: Both inspiratory and expiratory respiratory muscles are 
weakened in hypothyroidism in a direct linear relationship to the thyroid hormone 
level and it is reversible with thyroxine therapy. (Siafakas et al., 1992) Furthermore, 
thyroid deficient muscles have impaired free fatty acid utilization, which enhances their 
glycogen consumption, thereby reducing skeletal muscle endurance. (Baldwin et al., 
1980) One of the major inspiratory muscles that are involved in hypothyroidism is the 
diaphragm. Diaphragm weakness can be very severe and associated with 
hypoventilation. (Martinez et al., 1989, Laroche et al., 1988)  
- Pulmonary Vasculature: Both hyper/hypothyroidism has been associated with 
pulmonary arterial hypertension (PAH). (Li et al., 2007, Arroliga et al., 2000) A 
prevalence of 22-24% of hypothyroidism is reported in patients with PAH. (Curnock et 
al., 1999, Silva et al., 2009) It is thought that hypoxia/hypercapnia in hypothyroid 
patients is responsible for causing and worsening PAH. It is also known that both 
disorders are associated with autoimmune diseases, which raises the possibility of an 
immune pathyphysiological mechanism. (Badesch et al., 1993, Chu et al., 2002)   
4. Prevalence studies of hypothyroidism in OSA 
The first case reporting an apneic episode in a patient with myxedema was published in 
1964. (Massumi RA, 1964) Following that, studies have investigated further the prevalence 
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of OSA in hypothyroidism population and vice versa (Table 1).  Overall, the prevalence of 
clinical hypothyroidism in patients diagnosed with OSA or referred to sleep centers with 
a clinical suspicion of OSA is not higher than the prevalence in the general population. 
The prevalence in patients evaluated by polysomnography for OSA is 0.7-3.4%, 
depending on the upper limit set for normal TSH, gender and age distribution of the 
studied samples. (Lin CC, 1992, Meslier et al., 1992, Winkelman JW, 1996, Kapur VK and 
BM, 1998, Winkelman et al., 1996)  Kapur et al, reported a prevalence of 1.4% of 
subclinical hypothyroidism in OSA patients and this association was greater in females 
and those less than 50 years of age. (Kapur VK and BM, 1998) In a group of Taiwanese 
patients with OSA, a prevalence of 3.1% was reported despite using higher TSH level (>25 
mIU/l) to define hypothyroidism. (Lin et al., 1992) The prevalence is also not significantly 
different in patients highly suspected to have OSA (1.5%) than those already diagnosed to 
have OSA by overnight sleep study (2.4%). (Skjodt et al., 1999) This is similar to 
Winkelman and co-workers who reported a prevalence of 1.6% in patients suspected to 
have OSA and 2.9% in those confirmed to have OSA. (Winkelman et al., 1996)  Other 
studies have reported a much higher prevalence. In a study of 78 overweight and obese 
adult patients referred to a sleep clinic, a prevalence rate of 11.5% was reported. (Resta O, 
2004) The studied population was characterized by higher BMI, older age and more 
females. All these three variables are known risk factors for hypothyroidism, which might 
have resulted in a higher rate. (Sawin CT, 1979, Bilous and Tunbridge, 1988, Fox et al., 
2008) Females with OSA have been reported to have higher rates of undiagnosed and 
diagnosed hypothyroidism. (Winkelman et al., 1996, Alotair and Bahammam, 2008) In 
clinical practice, these variables are important to consider when assessing the risk of 
hypothyroidism in patients with suspected or diagnosed OSA. Female gender, increased 
BMI and older age are also well established risk factors for hypothyroidism. (Sawin CT, 
1979) This might explain the higher prevalence of hypothyroidism reported in some studies. 
(Resta O, 2004) Nevertheless, increased age and BMI are the main risk factors for OSA. 
(Punjabi, 2008, Hiestand et al., 2006) Thus, the co-existence of both diseases is expected 
and a high index of suspension is required in high risk patients. 
Some of the previous studies defined hypothyroidism as the presence of a high serum 
thyroid-stimulating hormone (TSH) level without commenting on thyroxine hormone level. 
This means that some of the patients thought to have hypothyroidism may actually have 
had subclinical hypothyroidism, which carries different therapeutic and prognostic 
implications (Miller and Husain, 2003, Winkelman et al., 1996, Pham and Shaughnessy, 
2008).  In a recent study, Bahammam et al. reported the prevalence of newly diagnosed 
clinical hypothyroidism as 0.4%, and the prevalence of newly diagnosed subclinical 
hypothyroidism as 11.1%. (Bahammam et al., 2011) In the non-OSA patients, the prevalence 
of newly diagnosed clinical hypothyroidism was reported as 1.4%, and the prevalence of 
newly diagnosed subclinical hypothyroidism as 4%. (Bahammam et al., 2011)  The authors 
concluded that the prevalence of newly diagnosed clinical hypothyroidism was low; 
however, subclinical hypothyroidism was common among patients with OSA. In lieu of the 
uncertainty of the benefit achieved by treating subclinical hypothyroidism, the authors 
recommended not to perform routine thyroid function testing for OSA patients. 
(Bahammam et al., 2011) 
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Table 1. Summary of the studies that assessed the prevalence of hypothyroidism in OSA 
patients.  
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5. Prevalence studies of OSA in hypothyroidism 
Limited data are available about the prevalence of OSA in hypothyroid patients (Table 2). 
The incidence is estimated to range from 25-82%. Most of the obtained data are from case 
reports and case series and their findings are variable. In a study of 50 patients with primary 
hypothyroidism, 30% where found to have OSA (AHI ≥5/hour). (Jha et al., 2006) These 
patients had overt severe hypothyroidism as manifested by TSH levels and symptoms. For 
milder cases and subclinical cases, the prevalence might be less. The variability in the results 
is influenced by the characteristics of the studied group. Predominance of male gender can 
result in a higher prevalence of OSA as it is one of the main risk factors for OSA. In smaller 
studies, a higher prevalence has been reported. (Rajagopal et al., 1984)    
 
 No. of 
Patients 
OSA Citeria No. of OSA (%) Patients Characteristics 
Jha A, et al (Jha 
et al., 2006) 
50 AHI≥ 
5/hour 
15 (30%) 
Mild OSA 8, 
Moderate 1, 
Severe 6 
Females 58%, Mean 
Age 34±11 years, 
Overweight 36%, 
Obese 16% 
Rajagopal et al 
(Rajagopal et 
al., 1984) 
11 -- 9 (82%) 
Mean AHI 
(71.8/hour) 
6 patients obese  
(AHI 99/hour) 
3 non-obese (AHI 
16.3/hour) 
Misiolek et al 
(Misiolek M 
and 2007) 
15 RDI> 
10/hour 
5 (33%) 11 Females, Mean Age 
50.3 (30-70) years, Mean 
BMI 29.2 (21.3-
41)kg/m2 
Lin et al (Lin et 
al., 1992) 
20 AHI≥ 
5/hour 
5 (25%) 
3 mild OSA, 2 
severe OSA 
4 Females, Mean Age 
49.4±7.3 years, IBW 
134.6±23.2% 
Hira et al (Hira 
HS, 1999) 
20  9 (45%) ----- 
Mikelson et al 
(Mickelson et 
al., 1999) 
10 RDI> 
10/hour 
4 (40%) ---- 
RDI: Respiratory Disturbance Index, IBW: Ideal Body Weight 
Table 2. Prevalence Studies of OSA in Hypothyroidism 
6. The clinical effects of treating hypothyroidism in OSA patients 
Theoretically, replacing thyroid hormone should reverse most if not all the complications 
associated with the state of deficiency. However, in real clinical practice, this is not 
absolutely correct. Changes such as respiratory muscle weakness can be reversible with 
thyroxine therapy. Difficult weaning in hypothyroid patients can be facilitated with 
thyroxine therapy too and mechanical obstruction due to thyroid goiter can be reverted with 
thyroidectomy. However, OSA response to thyroxine therapy is variable. In a case series of 
10 hypothyroid patients with OSA, treatment with thyroxine was associated with nocturnal 
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angina and arrhythmia in two patients. Initiation of CPAP therapy prevented angina and 
arrhythmia. Eight of these patients were followed after achieving euthyroid state and six of 
them had persistent sleep apnea requiring CPAP therapy. (Grunstein and Sullivan, 1988) 
Thereby, treatment of hypothyroidism in the presence of OSA can be potentially hazardous 
and lead to cardiovascular complications even with small doses of thyroxine as thyroxine 
therapy may increase metabolic rate in the presence of significant hypoxia. Combination 
therapy (CPAP + Thyroxine) can be helpful in such situation. In another series of nine 
hypothyroid patients with OSA (AHI range 17-176/hour), thyroxine therapy improved 
outcome. Six of them were obese and had the higher range of AHI and showed significant 
improvement in AHI after 3-12 months of thyroxine therapy despite no improvement in 
weight. (Rajagopal et al., 1984) Another series of 5 patients with OSA who received 
thyroxine therapy showed significant reduction in AHI after 4 months of therapy; however, 
snoring persisted and required longer duration of therapy to improve. (Lin et al., 1992) 
Snoring refers to upper airway resistance and the longer duration required to improve it is 
basically related to the duration needed to resolve or improve upper airway changes 
induced by hypothyroidism. In a larger group of patients, Resta and co-workers divided 
patients into 3 groups: group A: 63 patients with normal thyroid function, group B: 30 
patients affected with subclinical hypothyroidism and treated with levothyroxine for at least 
2 years and group C: 15 patients with TSH >4mIU/l and not treated with levothyroxine. 
(Resta et al., 2005) The prevalence and severity of OSA did not differ between the three 
groups and levothyroxine therapy did not influence OSA outcome in patients with 
subclinical hypothyroidism. It was also noticed that levothyroxine therapy in patients with 
subclinical hypothyroidism and OSA was associated with less daytime sleepiness as 
measured by the Epworth sleepiness scale when compared to the untreated group. (Resta et 
al., 2005) Untreated subclinical hypothyroidism by itself is a known cause of excessive 
daytime sleepiness measured both subjectively and objectively, which improved with 
thyroxine therapy. (Shinno et al., 2009) On the other hand, the outcome of treating primary 
hypothyroidism with levothyroxine in patients with OSA has resulted in a significant 
improvement in AHI within 7-11 months of therapy. This improvement was accompanied 
by significant reduction in BMI, skinfold thickness, pedal edema and other biochemical 
markers. (Jha et al., 2006) However, in the same study, two patients have lost follow-up and 
both failed to show any improvement in OSA following levothyroxine therapy. One is 
thought to be due to his overweight that did not reduce with therapy. (Jha et al., 2006) 
Failure to improve OSA by achieving euthyroid state suggests that hypothyroidism is not 
the only factor and other factors play a role in causing OSA.  It is also thought that thyroid 
hormone deficiency results in long term changes in the upper airway and thus improvement 
in OSA lags behind achieving the euthyroid state. (Grunstein et al., 1993) Furthermore, it is 
the treatment of the severe forms of hypothyroidism (myxedema) that improves the 
concomitant OSA. (Orr et al., 1981) Based on the available evidence, thyroxine cannot be 
considered as the only therapeutic option for OSA in patients with hypothyroidism 
especially in elderlies and those with cardiovascular diseases. (Veasey et al., 2006) The 
degree of hypoxia accompanying apneas may worsen with initiation of thyroxine therapy. 
In the hypothyroid state and as a result of the low metabolic rate, oxygen consumption by 
several body organs is less than usual, which can help to maintain a reasonable oxygen level 
compared to the duration and severity of apneas. With the increment in basal metabolic rate 
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seen with the commencement of thyroxine therapy, oxygen consumption is increased by 
body organs and short-duration apneas/hypopneas can result in dramatic oxygen 
desaturation. Therefore, CPAP therapy should not be delayed for months awaiting the 
results of thyroxine use. The lack of response to thyroxine suggests that either there is no 
casual association between hypothyroidism and OSA or those alterations in breathing 
mechanics and upper airways require longer duration of therapy to reverse them and that 
longer duration of follow up might show a beneficial effect of thyroxine therapy. 
 
 No. of 
Patients 
Mean 
Duration of 
Therapy 
Clinical Outcome of 
OSA 
Other Outcomes 
Jha A, et al 
(Jha et al., 
2006) 
12 9 months Significant 
improvement of AHI 
(14.3 (7.4–33.6)  to 2.1 
(0.8–4.6)) 
Significant 
improvement of 
BMI and skinfold 
thickness 
Rajagopal et 
al (Rajagopal 
et al., 1984) 
9 3-12 months AHI decreased 71.8 ± 
18.0  to 12.7 ± 6.1 
No change in BMI 
Misiolek et al 
(Misiolek M 
and 2007) 
5 5-6 months RDI persisted in two 
patients, increased in 
one, two patients 
showed insignificant 
reduction in RDI 
BMI and loud 
snoring improved 
Lin et al (Lin 
et al., 1992) 
5 One year Improved AI after 
4months of therapy 
Improved snoring 
after one year of 
therapy 
Improved hypoxic/ 
hypercapnic 
ventilator response 
after 4 months 
Hara et al, 
(Hira HS, 
1999) 
9 3 months 6 complete recovery, 
partial recovery in two 
and no recovery in one 
 
Table 3. Summary of outcome studies of thyroxine therapy in OSA patients 
7. Evaluating thyroid function in OSA patients 
It is important when ordering a laboratory investigation for any disease to consider the 
prevalence of the problem, the associated complications, cost-effectiveness and the 
effectiveness of treating the disease. Blood tests TSH, thyroxine (T4) are not clinically 
indicated in patients with OSA. Hypothyroidism can be associated with severe cases of 
OSA +/- hypoventilation but it is not an independent risk factor. Nocturnal upper airway 
obstruction has been evaluated in both hypothyroid and euthyroid subjects. The incidence 
of upper airway obstruction is higher in hypothyroid 7.7% compared to euthyroid 1.5% 
but after controlling for weight, age and gender, hypothyroidism does not significantly 
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predict upper airway obstruction. (Pelttari et al., 1994) Thus, upper airway obstruction is 
related to obesity and male gender and not to hypothyroidism per se. The prevalence of 
clinical hypothyroidism, as mentioned above, is not higher than the general population. 
Furthermore, there is no strong evidence to support the resolution of OSA with thyroxine 
therapy. However, thyroxine therapy should be initiated in hypothyroid patients to 
manage the other co-morbidities associated with hypothyroidism but not as a medical 
therapy for OSA. Thyroxine therapy can not abandon the need for CPAP therapy and 
should not delay its initiation. The recommended practice is to be selective when ordering 
TSH/T4 test to high risk population (females, morbidly obese and older age), persistent 
symptoms of fatigue and sleepiness despite proper CPAP therapy and in those with 
secondary causes for hypothyroidism (thyroid ablation, thyroidectomy, panpituitarism).  
8. Conclusion 
For OSA patients, the prevalence of clinical hypothyroidism is not higher than the general 
population. It is essential to consider the risk factors for hypothyroidism when evaluating 
patients for sleep apnea as well as considering OSA risk factors when evaluating 
hypothyroid cases. Routine blood testing for TSH and T4 should be saved for OSA patients 
with severe obesity, persistent sleepiness despite adequate CPAP therapy and with overt 
hypothyroid symptoms and signs. For hypothyroid patients with symptoms suggestive of 
OSA, a diagnostic sleep study is warranted and CPAP therapy should be commenced prior 
to thyroxine therapy especially in the elderly and patients with cardiovascular diseases. Re-
evaluating OSA patients after achieving euthyroid state can be done, especially if 
accompanied by weight reduction. Some of OSA cases might resolve but the majority seems 
to persist. Long-term studies might be able to explore better the impact of thyroxine therapy 
and help in understanding time-course of the problem. 
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